Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados

Pediatric Infectious Disease Journal

Volumn 22, Issue 5, 2003, Pages 422-425

  St John, Anne M ^a   Kumar, Alok ^b   Cave, Clyde ^b  

^a QUEEN ELIZABETH HOSPITAL   (Barbados)

^b NONE

Author keywords

Human immunodeficiency virus; Human immunodeficiency virus mother to child transmission; Perinatal transmission; Zidovudine

Indexed keywords

COTRIMOXAZOLE; ZIDOVUDINE;

ARTICLE; BARBADOS; BREAST MILK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MORTALITY; PERINATAL PERIOD; PNEUMOCYSTIS PNEUMONIA; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SERODIAGNOSIS; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; BARBADOS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE TRANSMISSION, VERTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; INFANT MORTALITY; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROBABILITY; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; ZIDOVUDINE;

EID: 0038586361     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200305000-00006     Document Type: Article

References (27)

1. Mofenson L, Stiehn ER, Lambert J, et al. Efficacy of zidovudine (ZDV) in reducing perinatal HIV transmission in HIV infected women with advanced disease [Abstract 1-117.65]. In: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997.
2. Boucher FD, Modlin JF, Weller S, et al. Phase 1 evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. J Pediatr 1993;122:1137-44.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
4. Frenkel LM, Wagner LE II, Demter LM, et al. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin Infect Dis 1995;20:1321-6.
5. Camara B, de Groulard M, Wagner U. CAREC HIV/AIDS Summary Report, 1999.
6. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal transmission: the French cohort study 7 years follow-up observation. J Acquir Def Syndr 1995;8:188-94.
7. Sperling R, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-8.
8. Aleixo LF, Gordenow MM, Sleasman JW. Zidovudine administered to females infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. J Pediatr 1997;130:906-14.
9. Oxtoby MJ. Vertically acquired HIV infection in the United States. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children and adolescents. 2nd ed. Baltimore: Williams & Wilkins, 1994:3-20.
10. Centers for Disease Control and Prevention. Administration of zidovudine during late pregnancy and delivery to prevent HIV infection in Thailand, 1996-1998. MMWR 1998;47:151-4.
11. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-14.
12. Shaffer N, Chuachoowong R, Mock P, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangcock, Thailand: a randomised control trial. Lancet 1999;353:733-80.
13. Gomez MP, Bain RM, Dean S, McNeil P, Read SE. Zidovudine reduces vertical transmission of HIV in the Bahamas In: A Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, Washington, DC, September 1997.
14. Jean SS, Pape JW, Verdier RI, et al. The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J 1999;18:58-63.
15. Jack N, Edwards J, Kuruvilla A, et al. Reduction of perinatal HIV transmission in Trinidad and Tobago: a pilot study [Abstract ThPeC5304]. In: International Conference on AIDS, 2000:13.
16. Carneio M, Sanchez P, Angelosante W, Perez C, Vallee M. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up. Placenta 2001;Suppl A:S13-8.
17. Mofenson LM. Short course zidovudine for prevention of perinatal infection. Lancet 1999;353:766-7.
18. Leroy V, Newell M-L, Dabis F, Peckham C. International multicentre pooled analysis of late postnatal mother to child transmission of HIV-1 infection. Lancet 1998;352:597-600.
19. Wiktor SZ, Ekpini E, Karon JM, et al. Short course oral zidovudine for prevention of mother to child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999;353:781-5.
20. Dabis F, Msellati P, Meda N, et al. Six month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breast fed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999;353:786-92.
21. Lallement M, Jourdain G, Le Coeur S, et al. Trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus typel. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000;343:982-91.
22. Patchen L, Khoshnood K. Risk of perinatal transmission with treatment combinations of intrapartum and newborn zidovudine monotherapy. AIDS Read 2001;5:274-5.
23. Marseille E, Kahn J, Mmiro F, Musoke P, Fowler M G, Jackson J. Cost effectiveness of single-dose nevirapine for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999;354:803-9.
24. Guay L, Musoke P, Flemming T, et al. Intrapartum and single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
25. Simpson JB, Shapiro ED, Andiman WA. Prospective cohort study of children born to human immunodeficiency virus-infected mothers, 1985 through 1997: trends in the risk of vertical transmission, mortality and acquired immunodeficiency syndrome indicator diseases in the era before highly active antiretroviral therapy. Pediatr Infect Dis J 2000;7:618-24.
26. Dunn NT, Newell ML, Ades A, Peckham C. Risk of human immunodeficiency virus type 1 transmission through breast feeding. Lancet 1992;340:585-8.
27. Nduati R, John G, Mbori-Ngasha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000;283:1167-74.